Influence of holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial

Author(s): Reiter, M. J., Freedman, R. A., Mann, D., Huang, S. K. S., Hahn, E., Hartz, V., Mason, J., Marcus, F. I., Caruso, A., Faitelson, H. L., Raya, T. E., Garcia, Z., Gear, K., Pierce, M. K., Pratt, C. M., Boahene, A., Pacifico, A., Wyndham, C., Francis, M., Kerr, C. R., Yeung, J. A., Vorderbrugge, S., Griffin, J. C., Lesh, M., Scheinman, M. M., Wong, M., Wong, M., Heyborne, T., Kenny, C., Bigger, J. T., Livelli, F. D., Steinberg, J. S., Campion, J., Squatrito, A. M., Mittleman, R., Collettwilley, P., Rofino, K., Saksena, S., Krol, R. B., Duque, L., Klein, R. C., Machell, C., Widman, M. L., Acostamiller, C., Lomeli, G., Kehoe, R., Zheutlin, T. A., Mattioni, T., etal.

Journal/Book: Prog Cardiovasc Dis. 1996; 38: Independence Square West, Curtis Center, Ste 300, Philadelphia, PA 19106-3399. W B Saunders Co. 359-370.

Note: Review JA Reiffel, Columbia Univ, 161 FT Washington Ave, Suite 349, New York, NY 10032 USA

Keyword(s): ANTIARRHYTHMIC-DRUG EFFICACY; PROGRAMMED ELECTRICAL-STIMULATION; HOSPITAL CARDIAC-ARREST; THERAPY; TACHYARRHYTHMIAS; REPRODUCIBILITY; INDUCTION; EXTRASTIMULI; ARRHYTHMIAS; SENSITIVITY

Zurück | Weiter